HIV 1 News and Research

RSS

Preventive measures needed to ensure protection from workplace hazards, ILO head says

Preventive measures are the best way to ensure people are protected from hazards in the workplace, U.N. International Labor Union Director-General Juan Somavia said in a message Thursday marking the World Day for Safety and Health at Work, the U.N. News Centre reports.

30 Apr 2011

Annapolis Coalition selects 7 behavioral health organizations for Pacesetter Award

Seven behavioral health organizations with outstanding business practices have been selected by the Annapolis Coalition on the Behavioral Health Workforce and the Hitachi Foundation as the 2011 National Behavioral Health Pacesetter Award Winners and Programs of Merit.

30 Apr 2011

AAHIVM praises Pennsylvania Senate's passage of legislation that reduces barriers to routine HIV testing

The American Academy of HIV Medicine, the nation's leading HIV care provider organization, praised the Pennsylvania State Senate today for the passage of legislation sponsored by state Sen. Ted Erickson (R-26) that reduces barriers to routine HIV testing.

30 Apr 2011

AHF advocates to attend drug giant Abbott Laboratories' Annual General Meeting

A group of advocates from AIDS Healthcare Foundation will attend drug giant Abbott Laboratories' Annual General Meeting Friday April 29 at 9:00am in Abbott Park, Illinois planning to speak at and question Abbott executives regarding Abbott's pricing and policies on its HIV/AIDS medications.

30 Apr 2011

Merck first quarter sales increase 1% to $11.6 billion for 2011

Merck, known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2011.

30 Apr 2011

ED providers need to assess STI risks in adolescents: Instructor of pediatrics

All adolescent females who show up in the emergency department complaining primarily of lower abdominal pain and/or urinary or genital symptoms should be tested for sexually transmitted infections, according to the authors of a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.

30 Apr 2011

WHO highlights global threat of NCDs, need for action at Moscow meeting

Non-communicable diseases are a "slow-moving catastrophe" that could overwhelm even the richest countries without action to address their underlying causes, WHO Director-General Margaret Chan said at the First Global Ministerial Conference on Healthy Lifestyles and Non-communicable Disease Control in Moscow on Thursday, the U.N. News Centre reports.

30 Apr 2011

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

Libya will run out of food within two months unless efforts are stepped up to get shipments into the war-torn country, the World Food Program warned on Thursday, Deustche Presse-Agentur/M&C reports.

30 Apr 2011

NeurogesX first quarter revenue is $3.2 million for 2011

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its first quarter ended March 31, 2011.

30 Apr 2011

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

João Gonçalves, from Faculdade de Farmácia e Instituto de Medicina Molecular, Lisbon, Portugal, to win a Grand Challenges Exploration Award

29 Apr 2011

Bill & Melinda Gates Foundation honors University Of Colorado researcher for preeclampsia study

A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.

29 Apr 2011

New innovative pilot project to combat surgical infections

Roughly one out of every 24 patients undergoing surgery acquires a surgical site infection. With 40 million operations performed in the U.S. each year, between 800,000 and 2 million individuals contract these infections annually.

29 Apr 2011

PURE Bioscience introduces new Hard Surface disinfectant

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate antimicrobial, today announced the launch of its proprietary new brand, PURE Hard Surface disinfectant and food contact surface sanitizer at the 2011 California State PTA Annual Convention being held April 28 - May 1 in Long Beach, California.

28 Apr 2011

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m.

28 Apr 2011

Non-communicable diseases responsible for more than half of deaths worldwide, WHO report says

Chronic and non-communicable illnesses, such as cancer, diabetes and heart disease, are at epidemic proportions and cause more deaths worldwide than all other diseases combined, the WHO said in a report released Wednesday, Reuters reports.

28 Apr 2011

IL28B gene plays a key role in spontaneous HCV clearance in infants

New research shows that high maternal viral load and co-infection with human immunodeficiency virus are the only risk factors associated with vertical transmission of the hepatitis C virus.

28 Apr 2011

MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool

Medecins Sans Frontieres recently sent a letter to Johnson & Johnson criticizing the pharmaceutical company for "refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries," the Star-Ledger reports.

27 Apr 2011

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced it has accepted delivery of the world's first integrated optical biosensor for disease diagnosis.

27 Apr 2011

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).

27 Apr 2011

African-American couples with HIV can benefit from health promotion interventions

Interventions to promote healthy behaviors, including eating more fruits and vegetables, increasing physical activity, and participating in cancer screenings, as well as prevention of HIV/sexually transmitted diseases, appear beneficial for African-American couples who are at high risk for chronic diseases, especially if one of the individuals is living with HIV.

26 Apr 2011

HIV 1 News and Research

Preventive measures needed to ensure protection from workplace hazards, ILO head says

Annapolis Coalition selects 7 behavioral health organizations for Pacesetter Award

AAHIVM praises Pennsylvania Senate's passage of legislation that reduces barriers to routine HIV testing

AHF advocates to attend drug giant Abbott Laboratories' Annual General Meeting

Merck first quarter sales increase 1% to $11.6 billion for 2011

ED providers need to assess STI risks in adolescents: Instructor of pediatrics

WHO highlights global threat of NCDs, need for action at Moscow meeting

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

NeurogesX first quarter revenue is $3.2 million for 2011

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

Bill & Melinda Gates Foundation honors University Of Colorado researcher for preeclampsia study

New innovative pilot project to combat surgical infections

PURE Bioscience introduces new Hard Surface disinfectant

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Non-communicable diseases responsible for more than half of deaths worldwide, WHO report says

IL28B gene plays a key role in spontaneous HCV clearance in infants

MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

African-American couples with HIV can benefit from health promotion interventions

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News